|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
EP0307434B2
(en)
|
1987-03-18 |
1998-07-29 |
Scotgen Biopharmaceuticals, Inc. |
Altered antibodies
|
|
EP1690935A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
AU664976B2
(en)
|
1990-08-29 |
1995-12-14 |
Gene Pharming Europe Bv |
Homologous recombination in mammalian cells
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
US6180377B1
(en)
|
1993-06-16 |
2001-01-30 |
Celltech Therapeutics Limited |
Humanized antibodies
|
|
US6130364A
(en)
|
1995-03-29 |
2000-10-10 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
|
US6410690B1
(en)
|
1995-06-07 |
2002-06-25 |
Medarex, Inc. |
Therapeutic compounds comprised of anti-Fc receptor antibodies
|
|
ES2253753T3
(es)
|
1995-06-29 |
2006-06-01 |
Immunex Corporation |
Citocina que induce apoptosis.
|
|
WO1998031383A1
(en)
|
1997-01-15 |
1998-07-23 |
Phoenix Pharmacologics, Inc. |
Modified tumor necrosis factor
|
|
PT1012274E
(pt)
|
1997-01-28 |
2007-08-14 |
Craig A Rosen |
Receptor 4 contendo um domínio de morte (dm4; receptor de morte 4), membro da super-família do ftn e ligação a liart (ap02)
|
|
US6072047A
(en)
|
1997-02-13 |
2000-06-06 |
Immunex Corporation |
Receptor that binds trail
|
|
NZ501831A
(en)
|
1997-06-26 |
2001-09-28 |
Immunex Corp |
Trail binding protein (TRAIL-BP) showing significant homology to the extracellular domains of members of the tumour necrosis factor receptor (TNF-R) and is anchored to cell surface via glycosylphosphatidylinositol (GPI) linkage
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
GB9809951D0
(en)
|
1998-05-08 |
1998-07-08 |
Univ Cambridge Tech |
Binding molecules
|
|
US6329148B1
(en)
|
1999-02-16 |
2001-12-11 |
The Board Of Trustees Of The Leland Stanford University |
Combined therapy of diterpenoid triepoxides and death domain receptor ligands for synergistic killing of tumor cells
|
|
US7534866B2
(en)
|
2005-10-19 |
2009-05-19 |
Ibc Pharmaceuticals, Inc. |
Methods and compositions for generating bioactive assemblies of increased complexity and uses
|
|
US7550143B2
(en)
|
2005-04-06 |
2009-06-23 |
Ibc Pharmaceuticals, Inc. |
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
|
|
CN1191273C
(zh)
|
1999-05-17 |
2005-03-02 |
康久化学公司 |
长效促胰岛肽
|
|
US7160924B2
(en)
|
2002-07-19 |
2007-01-09 |
The General Hospital Corporation |
Protein conjugates with a water-soluble biocompatible, biodegradable polymer
|
|
AU766984B2
(en)
|
1999-09-30 |
2003-10-30 |
Trustees Of The University Of Pennsylvania, The |
Trail: an inhibitor of autoimmune inflammation and cell cycle progression
|
|
IL136156A0
(en)
|
2000-05-16 |
2001-05-20 |
Compugen Ltd |
Sequences of trail variants
|
|
US20040005314A1
(en)
|
2001-07-27 |
2004-01-08 |
Enrique Escandon |
Apo-2l receptor agonist and cpt-11 synergism
|
|
KR100396983B1
(ko)
|
2000-07-29 |
2003-09-02 |
이강춘 |
고반응성의 가지 달린 고분자 유도체 및 고분자와 단백질또는 펩타이드의 접합체
|
|
KR20040023565A
(ko)
|
2000-09-18 |
2004-03-18 |
아이덱 파마슈티칼즈 코포레이션 |
Ｂ 세포 고갈/면역조절 항체 조합을 이용한 자가면역질환의 치료를 위한 조합 요법
|
|
KR20020056565A
(ko)
|
2000-12-29 |
2002-07-10 |
황규언 |
인간유래 세포 소멸 인자와 그 수용체의 결합체인ＴＲＡＩＬ-ｓＤＲ5 결합체의 결정화에 의한 3차원 구조및 ＴＲＡＩＬ 결실 돌연변이 단백질
|
|
US20020169123A1
(en)
|
2001-02-27 |
2002-11-14 |
The Trustees Of The University Of Pennsylvania |
Regulating apoptosis in TRAIL-resistant cancer cells, while protecting normal, non-cancerous cells
|
|
US7615233B2
(en)
|
2001-07-10 |
2009-11-10 |
Canon Kabushiki Kaisha |
Particulate construct comprising polyhydroxyalkanoate and method for producing it
|
|
DE10144252A1
(de)
|
2001-08-31 |
2003-03-27 |
Fraunhofer Ges Forschung |
Nanopartikel mit daran immobilisiertem biologisch aktivem TNF
|
|
US20040186051A1
(en)
|
2001-10-02 |
2004-09-23 |
Kelley Robert F |
Apo-2 ligand variants and uses thereof
|
|
US6908963B2
(en)
|
2001-10-09 |
2005-06-21 |
Nektar Therapeutics Al, Corporation |
Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
|
|
US7906118B2
(en)
|
2005-04-06 |
2011-03-15 |
Ibc Pharmaceuticals, Inc. |
Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
|
|
EP2500032A1
(en)
|
2002-06-24 |
2012-09-19 |
Genentech, Inc. |
APO-2 ligand/trail variants and uses thereof
|
|
EP1539210A4
(en)
|
2002-09-06 |
2006-06-07 |
Bayer Pharmaceuticals Corp |
GLP-1 RECEPTOR MODIFIED AGONISTS AND THEIR PHARMACOLOGICAL METHODS OF USE
|
|
US20050203142A1
(en)
|
2002-10-24 |
2005-09-15 |
Zeldis Jerome B. |
Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
|
|
JP2006506985A
(ja)
|
2002-10-30 |
2006-03-02 |
ファイザー・プロダクツ・インク |
コンパニオンアニマルのガンを診断および治療するための方法および組成物
|
|
GB2401040A
(en)
|
2003-04-28 |
2004-11-03 |
Chugai Pharmaceutical Co Ltd |
Method for treating interleukin-6 related diseases
|
|
EP1754713B1
(en)
|
2003-05-09 |
2009-02-25 |
Genentech, Inc. |
Apo2L (Trail) receptor binding peptides and uses thereof
|
|
US7186699B2
(en)
|
2003-06-03 |
2007-03-06 |
Cell Genesys, Inc. |
Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
|
|
US7795404B1
(en)
|
2003-08-08 |
2010-09-14 |
Five Prime Therapeutics, Inc. |
Human soluble notch receptor ligands
|
|
GB0328261D0
(en)
|
2003-12-05 |
2004-01-07 |
Univ Groningen |
Improved cytokine design
|
|
US20110020273A1
(en)
|
2005-04-06 |
2011-01-27 |
Ibc Pharmaceuticals, Inc. |
Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof
|
|
US8034352B2
(en)
|
2005-04-06 |
2011-10-11 |
Ibc Pharmaceuticals, Inc. |
Tetrameric cytokines with improved biological activity
|
|
US8003111B2
(en)
|
2005-04-06 |
2011-08-23 |
Ibc Pharmaceuticals, Inc. |
Dimeric alpha interferon pegylated site-specifically shows enhanced and prolonged efficacy in vivo
|
|
ES2246694B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
|
EP1786456A1
(en)
|
2004-06-18 |
2007-05-23 |
Genentech, Inc. |
Use of apo2l receptor agonists and nk cells or nk cell activators
|
|
JP2008505928A
(ja)
|
2004-07-08 |
2008-02-28 |
アムジェン インコーポレーテッド |
治療用ペプチド
|
|
US20060046961A1
(en)
*
|
2004-09-02 |
2006-03-02 |
Mckay William F |
Controlled and directed local delivery of anti-inflammatory compositions
|
|
BRPI0515615A
(pt)
|
2004-09-08 |
2008-07-29 |
Genentech Inc |
métodos para tratar células cancerosas e doença imune relacionada
|
|
JP2008516621A
(ja)
|
2004-10-18 |
2008-05-22 |
ノボ ノルディスク アクティーゼルスカブ |
成長ホルモン結合体
|
|
US8029783B2
(en)
|
2005-02-02 |
2011-10-04 |
Genentech, Inc. |
DR5 antibodies and articles of manufacture containing same
|
|
US20060188498A1
(en)
*
|
2005-02-18 |
2006-08-24 |
Genentech, Inc. |
Methods of using death receptor agonists and EGFR inhibitors
|
|
EP1695717A1
(en)
|
2005-02-23 |
2006-08-30 |
Ludwig-Maximilians-Universität |
Transport of nano-and macromolecular structures into cytoplasm and nucleus of cells
|
|
US20060228352A1
(en)
|
2005-02-24 |
2006-10-12 |
Schoenberger Stephen P |
TRAIL and methods of modulating T cell activity and adaptive immune responses using TRAIL
|
|
CN101484182B
(zh)
|
2005-04-06 |
2014-06-11 |
Ibc药品公司 |
由同二聚体、同四聚体或二聚体的二聚体组成的稳定连接复合体的生产方法及用途
|
|
AU2006232310B9
(en)
|
2005-04-06 |
2011-07-21 |
Ibc Pharmaceuticals, Inc. |
Improved stably tethered structures of defined compositions with multiple functions or binding specificities
|
|
US8158129B2
(en)
|
2005-04-06 |
2012-04-17 |
Ibc Pharmaceuticals, Inc. |
Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo
|
|
EP1745802A1
(en)
|
2005-07-20 |
2007-01-24 |
Kreatech Biotechnology B.V. |
Method of conjugating therapeutic compounds to cell targeting moieties via metal complexes
|
|
EP1937851A4
(en)
|
2005-10-19 |
2010-08-25 |
Ibc Pharmaceuticals Inc |
METHOD AND COMPOSITIONS FOR PRODUCING BIOACTIVE GROUPS OF INCREASED COMPLEXITY AND THEIR USE
|
|
GB0524316D0
(en)
|
2005-11-29 |
2006-01-04 |
Medical Res Council |
Tumour necrosis factor-related apoptosis-inducing ligands (TRAILs)
|
|
WO2007075534A2
(en)
|
2005-12-16 |
2007-07-05 |
Nektar Therapeutics Al, Corporation |
Polymer conjugates of glp-1
|
|
AU2007239095B2
(en)
|
2006-01-09 |
2012-05-03 |
The Regents Of The University Of California |
Immunostimulatory combinations for vaccine adjuvants
|
|
KR100784485B1
(ko)
|
2006-01-18 |
2007-12-11 |
한국과학기술연구원 |
생분해성 온도 감응성 폴리포스파젠계 하이드로젤, 그의제조방법 및 그의 용도
|
|
WO2007102690A1
(en)
|
2006-03-06 |
2007-09-13 |
Postech Foundation |
Vector including the codon-optimized dna cassette for producing secretory recombinant dodecamer trail
|
|
KR100746962B1
(ko)
|
2006-04-04 |
2007-08-07 |
한국과학기술연구원 |
온도 감응성 포스파젠계 고분자-생리 활성 물질 복합체,그의 제조방법 및 그의 용도
|
|
JO3324B1
(ar)
|
2006-04-21 |
2019-03-13 |
Amgen Inc |
مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
|
|
CN101074261A
(zh)
*
|
2006-04-30 |
2007-11-21 |
北京同为时代生物技术有限公司 |
Trail受体1和/或trail受体2特异性抗体及其应用
|
|
US8080248B2
(en)
|
2006-06-02 |
2011-12-20 |
Regeneron Pharmaceuticals, Inc. |
Method of treating rheumatoid arthritis with an IL-6R antibody
|
|
KR100886783B1
(ko)
|
2006-06-12 |
2009-03-04 |
성균관대학교산학협력단 |
N-말단이 수식된 peg-trail 결합체, 이의 제조방법 및 이의 용도
|
|
EP2044434B1
(en)
|
2006-06-20 |
2015-11-18 |
Genentech, Inc. |
Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components
|
|
BRPI0713484A2
(pt)
|
2006-06-21 |
2012-11-06 |
Apogenix Gmbh |
expressão diferencial de citocina em cáncer humano
|
|
US8008261B2
(en)
|
2006-08-04 |
2011-08-30 |
Mayo Foundation For Medical Education And Research |
Methods of reducing trail-induced apoptosis by trail isoforms
|
|
CN101578373A
(zh)
|
2006-09-06 |
2009-11-11 |
费斯生物制药公司 |
融合肽治疗组合物
|
|
WO2008120832A1
(en)
|
2007-03-30 |
2008-10-09 |
Industry-Academic Cooperation Foundation, Yonsei University |
Human neural stem cell secreting a smac, preparation method and use thereof
|
|
US8420598B2
(en)
|
2007-04-20 |
2013-04-16 |
B & L Delipharm Corp. |
Mono modified exendin with polyethylene glycol or its derivatives and uses thereof
|
|
KR100968591B1
(ko)
|
2007-06-14 |
2010-07-08 |
한국과학기술연구원 |
약물전달용 폴리포스파젠계 하이드로젤, 그의 제조방법 및그의 용도
|
|
BRPI0814645A2
(pt)
|
2007-07-25 |
2015-01-27 |
Alexion Pharma Inc |
Métodos e composições para tratar de doença autoimune.
|
|
CA2695991A1
(en)
|
2007-08-09 |
2009-02-12 |
Daiichi Sankyo Company, Limited |
Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor
|
|
US8440787B2
(en)
|
2007-10-23 |
2013-05-14 |
Nektar Therapeutics |
Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom
|
|
CN101932720A
(zh)
|
2007-10-31 |
2010-12-29 |
米迪缪尼有限公司 |
蛋白质支架
|
|
GB0723059D0
(en)
|
2007-11-23 |
2008-01-02 |
Nat Univ Ireland |
Improved cytokine design
|
|
US20090203671A1
(en)
|
2007-11-27 |
2009-08-13 |
Abbott Laboratories |
Method of treating cancer
|
|
GB0724532D0
(en)
|
2007-12-17 |
2008-01-30 |
Nat Univ Ireland |
Trail variants for treating cancer
|
|
JP5699362B2
(ja)
|
2008-04-10 |
2015-04-08 |
アイビーシー ファーマスーティカルズ，インコーポレイテッド |
薬物動態が改善された四量体サイトカインをドック・アンド・ロック（ｄｎｌ）技術により調製するためのモジュール法
|
|
CL2009001191A1
(es)
|
2008-05-14 |
2010-07-02 |
Genentech Inc |
Uso del peptido apo2l/trail porque sirve para preparar un medicamento para tratar el cancer de pulmon y el linfoma de hodkin.
|
|
US20100068302A1
(en)
|
2008-09-17 |
2010-03-18 |
Traslational Cancer Drugs Pharma, S.L. |
Methods and compositions for the treatment of cancer
|
|
CA2739663A1
(en)
|
2008-10-10 |
2010-05-15 |
Anaphore, Inc. |
Polypeptides that bind trail-r1 and trail-r2
|
|
US20120021995A1
(en)
|
2008-10-10 |
2012-01-26 |
Anaphore, Inc. |
Polypeptides that Bind TRAIL-R1 and TRAIL-R2
|
|
GB0818649D0
(en)
|
2008-10-10 |
2008-11-19 |
Nat Univ Ireland |
Treatment of proliferative disorders with trail
|
|
EA020843B1
(ru)
|
2009-02-03 |
2015-02-27 |
Амуникс Оперейтинг Инк. |
Удлиненные рекомбинантные полипептиды и содержащие их композиции
|
|
EP3903829B1
(en)
|
2009-02-13 |
2023-05-03 |
Immunomedics, Inc. |
Immunoconjugates with an intracellularly-cleavable linkage
|
|
CN101870728A
(zh)
|
2009-04-23 |
2010-10-27 |
派格生物医药(苏州)有限公司 |
新型Exendin变体及其缀合物
|
|
CN102481348A
(zh)
|
2009-08-31 |
2012-05-30 |
Ibc药品公司 |
双特异性免疫细胞因子停靠-和-加锁(dnl)复合物及其治疗性用途
|
|
WO2011079293A1
(en)
|
2009-12-23 |
2011-06-30 |
Ambrx, Inc |
Tumor necrosis factor-related apoptosis inducing ligand polypeptides and their uses
|
|
EP2519260A2
(en)
|
2009-12-31 |
2012-11-07 |
Deutsches Krebsforschungszentrum |
Novel modulators of trail signalling
|
|
WO2011106707A2
(en)
*
|
2010-02-26 |
2011-09-01 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to dr3
|
|
JP2013523179A
(ja)
|
2010-04-13 |
2013-06-17 |
メディミューン，エルエルシー |
フィブロネクチンタイプｉｉｉドメインに基づく多量体足場
|
|
US8461311B2
(en)
|
2010-06-08 |
2013-06-11 |
Washington University |
TRAIL trimers, methods and uses therefor
|
|
KR101209266B1
(ko)
|
2010-06-30 |
2012-12-06 |
한국과학기술연구원 |
생분해성 및 온도 감응성 폴리포스파젠계 자성 고분자, 그의 제조 방법 및 용도
|
|
HRP20160584T1
(hr)
|
2010-10-29 |
2016-06-17 |
Daiichi Sankyo Company, Limited |
Novo anti-dr5 antitijelo
|
|
EP2468764A1
(en)
|
2010-12-24 |
2012-06-27 |
Rijksuniversiteit te Groningen |
TNF family ligand variants
|
|
WO2012106281A2
(en)
|
2011-01-31 |
2012-08-09 |
The General Hospital Corporation |
Multimodal trail molecules and uses in cellular therapies
|
|
WO2012117336A2
(en)
|
2011-02-28 |
2012-09-07 |
Istituto Di Ricovero E Cura A Carattere Scientifico Materno-Infantile Burlo Garofolo - Ospedale Di Alta Specializzazione E Di Rilievo Nazionale Per La Salute Della Donna E Del Bambino |
Apoptosis-inducing molecules and uses therefor
|
|
JP2014510080A
(ja)
|
2011-03-09 |
2014-04-24 |
セントローズ， エルエルシー |
細胞外標的化薬物複合体
|
|
EP2686020B1
(en)
|
2011-03-17 |
2017-02-22 |
The University of Birmingham |
Re-directed immunotherapy
|
|
US20130101553A1
(en)
|
2011-04-18 |
2013-04-25 |
The Regents Of The University Of California |
Inducing inactivation of fibrogenic myofibroblasts
|
|
PT3679934T
(pt)
|
2011-04-29 |
2024-09-05 |
Penn State Res Found |
Indução do gene trail de pequenas moléculas por células normais e tumorais enquanto terapia anticancro
|
|
CA2834776A1
(en)
|
2011-05-03 |
2012-11-08 |
Genentech, Inc. |
Therapeutic apo2l/trail polypeptides and death receptor agonist antibodies
|
|
FI20115640A0
(fi)
|
2011-06-22 |
2011-06-22 |
Turun Yliopisto |
Yhdistelmähoito
|
|
US8586020B2
(en)
|
2011-06-30 |
2013-11-19 |
Korea Institute Of Science And Technology |
Poly(organophosphazene) composition for biomaterials
|
|
JP6208658B2
(ja)
|
2011-07-05 |
2017-10-04 |
バイオアシス テクノロジーズ インコーポレイテッド |
ｐ９７−抗体結合体および使用方法
|
|
CN111548425A
(zh)
|
2011-07-06 |
2020-08-18 |
江苏靶标生物医药研究所有限公司 |
一种肿瘤靶向性肿瘤坏死因子相关凋亡配体变体及其应用
|
|
CN102898526A
(zh)
|
2011-07-28 |
2013-01-30 |
山东先声麦得津生物制药有限公司 |
一种肿瘤坏死因子相关凋亡诱导配体融合蛋白及其制备和应用
|
|
GB201203442D0
(en)
|
2012-02-28 |
2012-04-11 |
Univ Birmingham |
Immunotherapeutic molecules and uses
|
|
US20150056204A1
(en)
|
2012-03-28 |
2015-02-26 |
Amgen Inc. |
Dr5 receptor agonist combinations
|
|
WO2013156054A1
(en)
|
2012-04-16 |
2013-10-24 |
Universität Stuttgart |
The igm and ige heavy chain domain 2 as covalently linked homodimerization modules for the generation of fusion proteins with dual specificity
|
|
WO2014018113A1
(en)
|
2012-07-24 |
2014-01-30 |
The General Hospital Corporation |
Oncolytic virus therapy for resistant tumors
|
|
US20150038511A1
(en)
|
2012-08-09 |
2015-02-05 |
Celgene Corporation |
Treatment of immune-related and inflammatory diseases
|
|
US9605074B2
(en)
|
2012-08-30 |
2017-03-28 |
The General Hospital Corporation |
Multifunctional nanobodies for treating cancer
|
|
EP2890986B1
(en)
|
2012-08-30 |
2017-06-21 |
Turun Yliopisto |
Method of selecting individualized brain cancer therapy
|
|
KR20150056846A
(ko)
|
2012-09-20 |
2015-05-27 |
모르포시스 아게 |
류마티스 관절염에 대한 치료
|
|
US20140134647A1
(en)
|
2012-11-01 |
2014-05-15 |
La Jolla Institute For Allergy And Immunology |
Novel crystal structure and ligand binding sites of trail receptor
|
|
JP6133431B2
(ja)
|
2012-11-24 |
2017-05-24 |
ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． |
親水性連結体及び薬物分子と細胞結合分子との共役反応における親水性連結体の使用
|
|
AU2013347838A1
(en)
|
2012-11-26 |
2015-06-11 |
Caris Life Sciences Switzerland Holdings Gmbh |
Biomarker compositions and methods
|
|
WO2014121093A1
(en)
*
|
2013-01-31 |
2014-08-07 |
Thomas Jefferson University |
Fusion proteins that facilitate cancer cell destruction
|
|
WO2014126537A1
(en)
|
2013-02-13 |
2014-08-21 |
Agency For Science, Technology And Research |
A Polymeric System for Release of an Active Agent
|
|
WO2015010615A1
(zh)
|
2013-07-23 |
2015-01-29 |
四川大学华西医院 |
一种重组trail蛋白及其制备方法和用途
|
|
JP6332773B2
(ja)
|
2013-09-02 |
2018-05-30 |
ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． |
薬物と細胞結合分子との共役のための新規細胞毒性分子
|
|
WO2015037000A1
(en)
|
2013-09-11 |
2015-03-19 |
Compugen Ltd |
Vstm5 polypeptides and uses thereof as a drug for treatment of cancer, infectious diseases and immune related diseases
|
|
PL222795B1
(pl)
|
2013-12-22 |
2016-09-30 |
Univ Warszawski |
Rekombinowane białko fuzyjne ProSTAT do zastosowania w leczeniu
|
|
US10464955B2
(en)
|
2014-02-28 |
2019-11-05 |
Hangzhou Dac Biotech Co., Ltd. |
Charged linkers and their uses for conjugation
|
|
US11299528B2
(en)
|
2014-03-11 |
2022-04-12 |
D&D Pharmatech Inc. |
Long acting TRAIL receptor agonists for treatment of autoimmune diseases
|
|
AU2015250039B2
(en)
|
2014-04-21 |
2018-03-22 |
D&D Pharmatech Inc. |
TRAIL receptor agonists for treatment of fibrotic diseases
|
|
US9901620B2
(en)
*
|
2014-04-21 |
2018-02-27 |
Theraly Pharmaceuticals, Inc. |
Trail receptor agonists for treatment of fibrotic disease
|
|
US10975112B2
(en)
|
2015-06-16 |
2021-04-13 |
Hangzhou Dac Biotech Co., Ltd. |
Linkers for conjugation of cell-binding molecules
|